FDA Issues Alert On Fake Antimalarial Drug

The Food and Drugs Authority (FDA) has issued an alert on fake COMBIART Tablets (Artemether/Lumefantrine 20/120) on the Ghanaian market.



In a public notice on February 22, 2023, the FDA said the flagged antimalarial drug has been falsified.



It explained that “samples of this drug from the Northern Region did not contain any of the two active pharmaceutical ingredients stated on the label, hence can be classified as falsified”. 



This was identified during market surveillance by the FDA.



The flagged drugs have 7225119 as batch number, 03/2021 as the manufacturing date, 02/2024 as the expiry date, Strides Arcolab Ltd as the manufacturer and A4-6700 as the NAFDAC Registration.



The Authority has therefore called on the public to be on the lookout.



“The FDA, therefore, wishes to inform health workers and the public to be on the lookout and report to the Authority the presence of this particular antimalarial drug- Combiart Tablets with the aforementioned details.”





Source: Fuseini

Related Articles

Back to top button